HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complementation Group B Xeroderma Pigmentosum

mutation in ERCC3 excision repair gene, which is also found in Cockayne syndrome
Also Known As:
Xeroderma Pigmentosum, Complementation Group B; Xeroderma Pigmentosum, Group B
Networked: 23 relevant articles (0 outcomes, 2 trials/studies)

Disease Context: Research Results

Related Diseases

1. Xeroderma Pigmentosum (Kaposi's Disease)
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
3. Inborn Genetic Diseases (Disease, Hereditary)
4. Philadelphia Chromosome
5. Ovarian Neoplasms (Ovarian Cancer)

Experts

1. Church, Trenton Mel: 1 article (01/2020)
2. Gabbard, Ryan D: 1 article (01/2020)
3. Hoopes, Robert R: 1 article (01/2020)
4. Kemp, Michael G: 1 article (01/2020)
5. Swaminathan, Sankar: 1 article (01/2020)
6. Verma, Dinesh: 1 article (01/2020)
7. Anderson, K C: 1 article (01/2018)
8. Arnulf, B: 1 article (01/2018)
9. Avet-Loiseau, H: 1 article (01/2018)
10. Awad, Keytam S: 1 article (01/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Complementation Group B Xeroderma Pigmentosum:
1. Proteins (Proteins, Gene)FDA Link
2. Protein Phosphatase 1IBA
3. Tyrosine (L-Tyrosine)FDA Link
4. Transcription Factor TFIIHIBA
5. DNA HelicasesIBA
6. Proliferating Cell Nuclear Antigen (PCNA)IBA
7. RNA Polymerase II (RNA Polymerase B)IBA
8. DNA (Deoxyribonucleic Acid)IBA
9. Proteasome Endopeptidase Complex (Proteasome)IBA
10. Cyclin-Dependent Kinases (cdk Proteins)IBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)